Becker's Healthcare November 19, 2024
Alexandra Murphy

As the medical device industry looks ahead to potential policies under the new administration, key decisions could shape the future of innovation, regulation and reimbursement in this sector.

Here are four factors to watch:

  1. During the first Trump administration, an executive order aimed to streamline Medicare coverage for FDA authorized “breakthrough devices” targeting life threatening conditions. These devices would have received four years of coverage to help manufacturers gather necessary evidence for permanent reimbursement. However, the policy was not implemented and was later scrapped by the Biden administration. As a result, industry advocates hope that the new Trump administration will revisit and expand Medicare coverage for breakthrough devices, The Wall Street Journal reported Nov. 14.
  2. If...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Medical Devices
What tariffs mean for the medical device industry - and who will pay for them?
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio

Share This Article